147 related articles for article (PubMed ID: 38806877)
21. Early access programs: Benefits, challenges, and key considerations for successful implementation.
Patil S
Perspect Clin Res; 2016; 7(1):4-8. PubMed ID: 26955570
[TBL] [Abstract][Full Text] [Related]
22. Emergency Preparedness of Secondary School Athletic Programs in Arizona.
McLeod TCV; Cardenas JF
J Athl Train; 2019 Feb; 54(2):133-141. PubMed ID: 30517023
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of a pharmacist-led workflow for the FDA Expanded Access Program.
Barta BT; McGee A; Arvik BML; Vest TA
Am J Health Syst Pharm; 2024 Mar; ():. PubMed ID: 38527421
[TBL] [Abstract][Full Text] [Related]
24. Backpropagation of action potentials generated at ectopic axonal loci: hypothesis that axon terminals integrate local environmental signals.
Pinault D
Brain Res Brain Res Rev; 1995 Jul; 21(1):42-92. PubMed ID: 8547954
[TBL] [Abstract][Full Text] [Related]
25. Characterizing expanded access and compassionate use programs for experimental drugs.
Miller JE; Ross JS; Moch KI; Caplan AL
BMC Res Notes; 2017 Jul; 10(1):350. PubMed ID: 28754150
[TBL] [Abstract][Full Text] [Related]
26. Expanded Access Programs: Ethical and Practical Considerations for Biopharmaceutical Sponsors.
Klopfenstein M; Van Campen LE; Garnett T
Ther Innov Regul Sci; 2015 May; 49(3):352-358. PubMed ID: 29473010
[TBL] [Abstract][Full Text] [Related]
27. Is it time to rethink the expanded-access programs for HIV infection?
Amorosa V; Tebas P
J Infect Dis; 2007 Oct; 196(7):974-7. PubMed ID: 17763316
[TBL] [Abstract][Full Text] [Related]
28. MoodHacker Mobile Web App With Email for Adults to Self-Manage Mild-to-Moderate Depression: Randomized Controlled Trial.
Birney AJ; Gunn R; Russell JK; Ary DV
JMIR Mhealth Uhealth; 2016 Jan; 4(1):e8. PubMed ID: 26813737
[TBL] [Abstract][Full Text] [Related]
29. Employed women with alcohol problems who seek help from employee assistance programs. Description and comparisons.
Blum TC; Roman PM; Harwood EM
Recent Dev Alcohol; 1995; 12():125-56. PubMed ID: 7624538
[TBL] [Abstract][Full Text] [Related]
30. Modelling approaches for histology-independent cancer drugs to inform NICE appraisals: a systematic review and decision-framework.
Murphy P; Glynn D; Dias S; Hodgson R; Claxton L; Beresford L; Cooper K; Tappenden P; Ennis K; Grosso A; Wright K; Cantrell A; Stevenson M; Palmer S
Health Technol Assess; 2021 Dec; 25(76):1-228. PubMed ID: 34990339
[TBL] [Abstract][Full Text] [Related]
31. Abacavir expanded access program for adult patients infected with human immunodeficiency virus type 1.
Kessler HA; Johnson J; Follansbee S; Sension MG; Mildvan D; Sepulveda GE; Bellos NC; Hetherington SV
Clin Infect Dis; 2002 Feb; 34(4):535-42. PubMed ID: 11797183
[TBL] [Abstract][Full Text] [Related]
32. Optimising oncology drug expenditure in Ireland.
Kieran R; Hennessy M; Coakley K; O'Sullivan H; Cronin T; Lynch D; Mulroe E; Cooke K; Collins D; O'Reilly S
Ir J Med Sci; 2024 Apr; ():. PubMed ID: 38568369
[TBL] [Abstract][Full Text] [Related]
33. What do patients with unmet medical needs want? A qualitative study of patients' views and experiences with expanded access to unapproved, investigational treatments in the Netherlands.
Bunnik EM; Aarts N
BMC Med Ethics; 2019 Nov; 20(1):80. PubMed ID: 31706313
[TBL] [Abstract][Full Text] [Related]
34. The New Paradigms in Clinical Research: From Early Access Programs to the Novel Therapeutic Approaches for Unmet Medical Needs.
Scavone C; di Mauro G; Mascolo A; Berrino L; Rossi F; Capuano A
Front Pharmacol; 2019; 10():111. PubMed ID: 30814951
[TBL] [Abstract][Full Text] [Related]
35. Alcohol & drug abuse: Revisiting employee assistance programs and substance use problems in the workplace: key issues and a research agenda.
Merrick ES; Volpe-Vartanian J; Horgan CM; McCann B
Psychiatr Serv; 2007 Oct; 58(10):1262-4. PubMed ID: 17914000
[TBL] [Abstract][Full Text] [Related]
36. INGN 201: Ad-p53, Ad5CMV-p53, adenoviral p53, p53 gene therapy--introgen, RPR/INGN 201.
Drugs R D; 2007; 8(3):176-87. PubMed ID: 17472413
[TBL] [Abstract][Full Text] [Related]
37. A geometric framework for ensemble average propagator reconstruction from diffusion MRI.
Vemuri BC; Sun J; Banerjee M; Pan Z; Turner SM; Fuller DD; Forder JR; Entezari A
Med Image Anal; 2019 Oct; 57():89-105. PubMed ID: 31295681
[TBL] [Abstract][Full Text] [Related]
38. Diffeomorphism invariant Riemannian framework for ensemble average propagator computing.
Cheng J; Ghosh A; Jiang T; Deriche R
Med Image Comput Comput Assist Interv; 2011; 14(Pt 2):98-106. PubMed ID: 21995018
[TBL] [Abstract][Full Text] [Related]
39. Report of an international expanded access program of imatinib in adults with Philadelphia chromosome positive leukemias.
Capdeville R; Krahnke T; Hatfield A; Ford JM; Van Hoomissen I; Gathmann I
Ann Oncol; 2008 Jul; 19(7):1320-1326. PubMed ID: 18344535
[TBL] [Abstract][Full Text] [Related]
40. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
